Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
42 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06991738 | 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer | not yet recruiting | Phase 1 / Phase 2 | 18 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 30, 2026 | clinicaltrials |
| NCT00001254 | Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome | completed | — | 273 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| 1 |
| Sep 28, 2026 |
| clinicaltrials |
| NCT00001276 | Diagnosing and Treating Low Blood Sugar Levels | recruiting | — | 1,500 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT00646022 | Natural History of Familial Carcinoid Tumor | recruiting | — | 1,600 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT03520660 | People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents | active not recruiting | Phase 4 | 121 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT04969926 | Natural History Study of Parathyroid Disorders | recruiting | — | 3,000 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 17, 2026 | clinicaltrials |
| NCT03374215 | Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks | recruiting | — | 1,150 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT04927416 | The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer | recruiting | Phase 2 | 54 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT05398783 | A Natural History Study of Metabolic Sizing in Health and Disease | recruiting | — | 2,000 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 15, 2026 | clinicaltrials |
| NCT03049462 | The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists | completed | Phase 1 | 55 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 9, 2026 | clinicaltrials |
| NCT03841617 | The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer | recruiting | Phase 2 | 30 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 9, 2026 | clinicaltrials |
| NCT01109420 | Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer | recruiting | — | 500 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 8, 2026 | clinicaltrials |
| NCT00001160 | Studies on Tumors of the Thyroid | recruiting | — | 2,500 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Aug 31, 2026 | clinicaltrials |
| NCT00038727 | Diabetes Prevention Program Outcomes Study(DPPOS) | completed | Phase 3 | 2,779 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07444723 | Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors | recruiting | Phase 2 / Phase 3 | 193 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jun 2, 2026 | clinicaltrials |
| NCT00059267 | Prevention of Recurrent Hepatitis B After Liver Transplantation | completed | — | 317 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Nov 15, 2024 | clinicaltrials |
| NCT00290251 | Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914 | completed | Phase 2 | 72 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jul 15, 2024 | clinicaltrials |
| NCT00001345 | Studies of Inherited Diseases of Metabolism | completed | — | 969 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jan 20, 2023 | clinicaltrials |
| NCT00001277 | Studies of Elevated Parathyroid Activity | completed | Phase 2 | 1,553 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jun 7, 2022 | clinicaltrials |
| NCT04729296 | Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D | withdrawn | Phase 2 | 0 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 0 | Dec 2, 2021 | clinicaltrials |
| NCT00001981 | The Treatment and Natural History of Acromegaly | completed | — | 117 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Nov 27, 2020 | clinicaltrials |
| NCT01441154 | Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment | completed | — | 16 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 28, 2020 | clinicaltrials |
| NCT00719641 | Experimental Device to Improve Colonoscopy | completed | — | 42 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 24, 2020 | clinicaltrials |
| NCT00825877 | Long-term Follow-up of HALT-C Sustained Virological Responders | completed | — | 140 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT00054756 | Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities | completed | Phase 2 | 96 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Aug 8, 2018 | clinicaltrials |
| NCT00111956 | Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome | completed | Phase 2 / Phase 3 | 56 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00001191 | The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid | completed | Phase 2 | — | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00001228 | Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer | completed | Phase 2 | 50 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00001241 | Treatment of Zollinger-Ellison Syndrome | completed | — | — | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00325104 | Cinacalcet to Treat Familial Primary Hyperparathyroidism | completed | Phase 3 | 25 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00212264 | Conservative Treatment of Postprostatectomy Incontinence | completed | N/A | 208 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Apr 11, 2016 | clinicaltrials |
| NCT00279292 | Randomized Trial of EUS Neurolysis in Pancreas Cancer | completed | Phase 3 | 26 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00251316 | Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer | completed | Phase 2 | 34 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00048841 | Prevention of Osteoporosis in Men With Prostate Cancer | completed | Phase 3 | 112 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00001240 | Evaluating Patients With Abnormal Levels of Gastric Acid | completed | — | — | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 5, 2008 | clinicaltrials |
| NCT00001165 | Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas | completed | Phase 2 | 999 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001394 | Using X-Ray Dye to Locate Hidden Parathyroid Tumors | completed | — | 150 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001730 | Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. | completed | Phase 4 | 20 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001860 | Sandostatin LAR Depot vs. Surgery for Treating Acromegaly | completed | Phase 2 | 5 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005785 | Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer | completed | Phase 1 | 30 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005910 | Laparoscopy to Remove Pancreatic Tumors (Insulinomas) | completed | N/A | 23 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00080574 | The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients | completed | Phase 2 | 20 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
Data updated 13 hours agoSource updated unknownsource: clinicaltrials